3-Bromo-2,6-dimethylpyridine | CAS:3430-31-7

We serve 3-Bromo-2,6-dimethylpyridine CAS:3430-31-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-Bromo-2,6-dimethylpyridine

Chemical Name:3-Bromo-2,6-dimethylpyridine
CAS.NO:3430-31-7
Synonyms:3-Bromo-2,6-dimethylpyridine
3-Bromo-6-methyl-2-picoline
3-bromo-2,6-lutidine
Molecular Formula:C7H8BrN
Molecular Weight:186.04900
 
Physical and Chemical Properties:
Density:1.415
Boiling point:56-58ºC
Flash point:71.4ºC
Index of Refraction:1.547
 
Specification:
Appearance:Colorless clear liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 3-Bromo-2,6-dimethylpyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-bromo-2,6-lutidine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Bromo-2,6-dimethylpyridine Use and application,3-Bromo-2,6-dimethylpyridine technical grade,usp/ep/jp grade.


Related News: China will use its national drug bulk-buy scheme to lower the price of drugs currently sold at higher prices compared with other markets, it said in an official statement.(3S)-3-(4-Nitro-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione manufacturer British Airways, Qantas and Lufthansa — among others — have announced they will stop flying to mainland China. Other airlines are reducing the number of flights.4-(4-bromo-2-fluoroanilino)-6-methoxy-1H-quinazolin-7-one supplier British Airways, Qantas and Lufthansa — among others — have announced they will stop flying to mainland China. Other airlines are reducing the number of flights.(Z)-2-(2-Aminothiazol-4-yl)-2-(hydroxyimino)acetic acid vendor British Airways, Qantas and Lufthansa — among others — have announced they will stop flying to mainland China. Other airlines are reducing the number of flights.The overall competition in China’s specialty drug substance market is relatively moderate, but due to the higher technical barriers and higher entry barriers for new entrants, there will be no obvious intensified competition in the short term.